RLAY- Relay Therapeutics, Inc.

Trade Summary

2 days ago, Bergstrom Donald A, serving as President, R&D at Relay Therapeutics, Inc. (RLAY), sold 8,530 shares at $18.97 per share, for a total transaction value of $161,814.10. Following this transaction, Bergstrom Donald A now holds 399,130 shares of RLAY.

This sale represents a 2.09% decrease in Bergstrom Donald A's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, September 8, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, September 9, 2026 at 4:17 PM ET, 1 day after the trade was made.

Relay Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.